Our Matthew Burke joined Corina Turner, from our partner Smart in Media for a conversation on how AI creates measurable value for pathology labs already today.
There are proven benefits of AI in clinical diagnostic: Higher accuracy, better reproducibility, clear clinical potential. But budget holders will still ask: Where’s the financial return? What is the value of AI in pathology?
This webinar answers the question by showing how customers already see and measure value in their daily routine.
What you’ll learn:
- How AI in clinical practice is more than fancy algorithms
- Key drivers behind successful adoption and scalability
- Real world evidence of tangible benefits for labs
- How AI can support both clinical outcomes and operational efficiency
AI in pathology won’t get funded on accuracy alone. But there is more to the story.
Visiopharm’s IVDR certified APPs can be integrated into Smart in Media’s PathoZoom® Digital Lab IMS for an optimized workflow.
About Smart in Media
As one of the world’s leading providers of digital pathology software, their PathoZoom® solutions support pathologists in effective diagnostics and teaching, from small solutions to full digitization. With many years of experience, their teams in Europe and USA support you from small solutions to full digitization.
Matthew Burke, PhD
Matthew Burke, PhD, is a business development leader specializing in digital pathology and AI-driven precision diagnostics. He brings over a decade of experience advancing digital pathology adoption at companies such as Philips, Hamamatsu, and now Visiopharm. His work focuses on expanding access to technologies that improve diagnostic accuracy, efficiency, and ultimately, patient outcomes.
